10 January 2024
Freshfields Advising AstraZeneca in Acquisition of Gracell Biotechnologies Inc. Furthering the AstraZeneca Cell Therapy
Advising firms
Deal team
35 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Sebastian Fain Lead | Freshfields | Partner | corporate/M&A | Not stated |
| Zheng (Jonathan) Zhou Lead | Freshfields | Partner | corporate/M&A | Not stated |
| Abigail G. Hathaway | Freshfields | Senior associate | corporate/M&A | Not stated |
| Jenny Park | Freshfields | Associate | corporate/M&A | Not stated |
| Chinyere Obi | Freshfields | Associate | corporate/M&A | Not stated |
| Marvin Galloway | Freshfields | Associate | corporate/M&A | Not stated |
| Ruth Levy | Freshfields | Associate | corporate/M&A | Not stated |
| Ya Ma | Freshfields | Not stated | corporate/M&A | Beijing |
| Jeff Jay | Freshfields | Counsel | life sciences | Not stated |
| Madeleine Tavcar | Freshfields | Associate | life sciences | Not stated |
| Dylan O'Connor | Freshfields | Associate | life sciences | Not stated |
| Shannon O'Hara | Freshfields | Associate | life sciences | Not stated |
| Nicole Foster | Freshfields | Partner | executive compensation and benefits | Not stated |
| Sarah Ghulamhussain | Freshfields | Partner | executive compensation and benefits | Not stated |
| Stephanie Chiu | Freshfields | Counsel | executive compensation and benefits | Not stated |
| Lina Zhu | Freshfields | Associate | executive compensation and benefits | Not stated |
| Meilun Chen | Freshfields | Associate | executive compensation and benefits | Not stated |
| May Smith | Freshfields | Partner | tax | Not stated |
| Claude Stansbury | Freshfields | Partner | tax | Not stated |
| Rose Swaffield | Freshfields | Senior associate | tax | Not stated |
| Hannah Golden | Freshfields | Associate | tax | Not stated |
| Mary Lehner | Freshfields | Partner | competition | Not stated |
| Simon Priddis | Freshfields | Partner | competition | Not stated |
| Jenny Leahy | Freshfields | Partner | competition | Not stated |
| Ninette Dodoo | Freshfields | Partner | competition | Not stated |
| Laura Onken | Freshfields | Counsel | competition | Not stated |
| Kristy Brown | Freshfields | Associate | competition | Not stated |
| Tim Swartz | Freshfields | Associate | competition | Not stated |
| Kara King | Freshfields | Associate | competition | Not stated |
| Christine Laciak | Freshfields | Counsel | foreign investment | Not stated |
| Stephanie Brown Cripps | Freshfields | Partner | sanctions | Not stated |
| Marcus Levy | Freshfields | Associate | sanctions | Not stated |
| Christine Lyon | Freshfields | Partner | privacy and cybersecurity | Not stated |
| Brock Dahl | Freshfields | Partner | privacy and cybersecurity | Not stated |
| Maria Paz Lestido | Freshfields | Associate | privacy and cybersecurity | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- AstraZenecaBuy-side
- Counterparties
- Gracell Biotechnologies Inc. (Target)